Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Roche licenses PCR technology to Immuno

July 12, 1996

GenPharm describes high-affinity human IgG monoclonal antibodies

July 12, 1996

LCR Technology covered under U.S. patent

July 12, 1996

SmithKline Beecham/Human Genome Sciences human genome collaboration no longer exclusive

July 12, 1996

Oculex receives grants for ocular drug delivery research

July 12, 1996

Heliosynthese and Scotia receive EEC Eureka award for microalgae research

July 12, 1996

Phytera and Tsumura Juntendo collaborate in rheumatoid arthritis/allergy R&D

July 12, 1996

Collaboration on signal transduction inhibitor drug discovery announced

July 12, 1996

Arris issued U.S. patent for drug design technology

July 12, 1996

Arris, SKB to research protease inhibitors

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...